SpeedCaptionsQuality

Blood test for Alzheimer's goes on sale without FDA approval

CBS News 1,876 viewsMore from this channel

St. Louis-based C2N Diagnostics has released a blood test that it says can detect Alzheimer's disease. The test is not yet FDA approved, and is not covered by insurance, costing up to $1,250. Northwell Health internal medicine specialist Dr. Karen Abrashkin joins CBSN's Anne-Marie Green to talk about the latest development in the fight against Alzheimer's, which affects nearly 6 million Americans.

Blood test for Alzheimer's goes on sale without FDA approval

Suggested videos

Update to network connecting ATC system led to outage before ground stop, sources say

FDA approves first blood test to help screen for Alzheimer's disease

What we know about nationwide FAA ground stop, Mullin says no indication of attack | Special Report

FDA approves first blood test to diagnose Alzheimer's

Some international flights allowed to depart U.S. amid FAA ground stop

What to know about new FDA-approved blood test for detecting Alzheimer's

Mullin says FAA ground stop caused by telecommunications outage

FDA clears blood test from Roche and Lilly for Alzheimer's diagnosis

Here’s how Hegseth reacted after soldier reminded his group about decorum at sacred Arlington tomb

FDA approves new blood test for Alzheimer’s

BREAKING NEWS: National FAA ground stop impacting all airports, including DFW Airport

The FDA Just Approved The First Alzheimer’s Blood Test